Medicure (TSXV:MPH) FFO


TSXV:MPH Medicure Inc TSXV:MPH
52 GF Score
Price C$1.06
GF Value C$1.56
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Medicure FFO?

FFO (Funds from operations) only applies to REITs.

TSXV:MPH
52GF Score
Medicure Inc TSXV:MPH
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Medicure (TSXV:MPH) Overvalued in 2026?

Based on GuruFocus' analysis, Medicure stock appears to be undervalued. The current stock price of C$1.06 is trading 32.1% below its estimated GF Value™ of C$1.56. GuruFocus considers Medicure to be Possible Value Trap.

Key valuation signals for TSXV:MPH:

  • FFO:
  • GF Value™: C$1.56 vs. price of C$1.06 (32.1% below fair value)
  • GF Score™: 52/100 with 4 warning signs

No single metric tells the full story. See the TSXV:MPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medicure Business Description

Other Exchanges MCUJF:USA
Address 1250 Waverley Street, No. 2, Winnipeg, MB, CAN, R3T 6C6
Medicure Inc is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market and sales to the Retail Public of pharmaceutical products. The Company's present focus is the sale and marketing of its cardiovascular products, AGGRASTAT, ZYPITAMAG, and increasing its e-commerce and mail order pharmaceutical business. The Company operates under two segments: the marketing and distribution of commercial products and the operation of a retail and mail order pharmacy. It generates the majority of its revenue from the Retail and Mail Order Pharmacy segment.
52GF Score

Get the complete analysis for TSXV:MPH

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$1.06
Price
C$1.56
GF Value